/Morrison_Foerster.gif)
/Medicon_Valley_2016.jpg)
Danish Scientist Awarded 1st Prize for Research
Dr Morten Dahl from Herlev University Hospital is this year's winner of the European Respiratory Society's annual award for research in the field of Chronic Obstructive Pulmonary Disease.
The international medical organisation, The European Respiratory Society (ERS), has awarded their annual prize for research in the field of Chronic Obstructive Pulmonary Disease (COPD). This year, the first prize of 30,000 Euros went to the Danish scientist Morten Dahl, Herlev University Hospital, for his assessment of risk for COPD in individuals with increased systemic inflammation and less severe alpha-1 antitrypsin deficiency.
C-reactive protein as predictor of future COPD
His research may aid the identification of new biomarkers for COPD and asthma. In his recent research Dahl tested whether increased concentrations of C-reactive protein (CRP) predict future risk of hospitalization and death from COPD in individuals with airway obstruction. The study showed that serum CRP is a strong predictor of future COPD in individuals with airway obstruction.
The ERS COPD Research Award recognises the work of young European ERS members active in pulmonology research and has been awarded for the seventh time this year.
For further information visit the Boehringer Ingelheims homepage.
